Featured Research

from universities, journals, and other organizations

Among patients with infective endocarditis and heart failure, valvular surgery associated with reduced mortality

Date:
November 29, 2011
Source:
JAMA and Archives Journals
Summary:
Among patients with infective endocarditis and heart failure, about two-thirds undergo valvular surgery, which is associated with a significant reduction in the risk of death in the hospital and at one year, according to a new study.

Among patients with infective endocarditis (an infection of the heart lining which may involve the heart valves) and heart failure, about two-thirds undergo valvular surgery, which is associated with a significant reduction in the risk of death in the hospital and at one year, according to a study in the Nov. 23/30 issue of JAMA.

Related Articles


"Infective endocarditis is associated with substantial morbidity and mortality. Several published studies have reported in-hospital mortality of 15 percent to 20 percent and l-year mortality of 40 percent. In the United States alone, approximately 15,000 new cases of infective endocarditis are diagnosed each year. A variety of complications contribute to the high rates of morbidity and mortality in infective endocarditis, particularly heart failure (HF), which occurs in approximately 40 percent of patients," according to background information in the article. Several observational studies have shown a reduction in the risk of death for infective endocarditis complicated by HF with valvular surgery, and this indication for surgery is strongly recommended in current American College of Cardiology/American Heart Association and European Society of Cardiology guidelines.

Todd Kiefer, M.D., Ph.D., of Duke University Medical Center, Durham, N.C., and colleagues conducted a study to examine the clinical, echocardiography, and microbiological variables associated with the development of HF in patients with infective endocarditis and examined variables associated with in-hospital and 1-year mortality, including the use and effects of surgery on outcome. The study included 4,166 patients with native- or prosthetic-valve infective endocarditis from 61 centers in 28 countries between June 2000 and December 2006.

Among 4,075 patients with infective endocarditis and known HF status, 1,359 (33.4 percent) had HF, and 906 (66.7 percent) were classified as having New York Heart Association class III or IV symptom status (greater degree of limitations/symptoms with physical activity). Within the subset with HF, 839 (61.7 percent) underwent valvular surgery during the index hospitalization. The researchers found that in-hospital mortality was 29.7 percent for the entire HF cohort, with lower mortality observed in patients undergoing valvular surgery compared with medical therapy alone (20.6 percent vs. 44.8 percent, respectively). In addition, one-year mortality was 29.1 percent in patients undergoing valvular surgery vs. 58.4 percent in those not undergoing surgery.

Factors independently associated with 1-year mortality included advanced age, diabetes mellitus, health care-associated infection, causative microorganism (Staphylococcus aureus or fungi), severe HF (New York Heart Association class III or IV), stroke, and paravalvular complications. Valvular surgery during the initial hospitalization was associated with lower mortality.

The authors note that their finding that nearly one-third of patients with HF and high surgical propensity did not have surgery emphasizes the need for multi-disciplinary, guideline-based management of infective endocarditis. "Improved recognition of HF and institutional systems to promote appropriate treatment of infective endocarditis may enhance the rate of surgery for this indication."

"Additional studies are needed to better risk-stratify patients with infective endocarditis and HF and optimize the use of surgery for this serious condition."


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Journal Reference:

  1. T. Kiefer, L. Park, C. Tribouilloy, C. Cortes, R. Casillo, V. Chu, F. Delahaye, E. Durante-Mangoni, J. Edathodu, C. Falces, M. Logar, J. M. Miro, C. Naber, M. F. Tripodi, D. R. Murdoch, P. Moreillon, R. Utili, A. Wang. Association Between Valvular Surgery and Mortality Among Patients With Infective Endocarditis Complicated by Heart Failure. JAMA: The Journal of the American Medical Association, 2011; 306 (20): 2239 DOI: 10.1001/jama.2011.1701

Cite This Page:

JAMA and Archives Journals. "Among patients with infective endocarditis and heart failure, valvular surgery associated with reduced mortality." ScienceDaily. ScienceDaily, 29 November 2011. <www.sciencedaily.com/releases/2011/11/111122162822.htm>.
JAMA and Archives Journals. (2011, November 29). Among patients with infective endocarditis and heart failure, valvular surgery associated with reduced mortality. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2011/11/111122162822.htm
JAMA and Archives Journals. "Among patients with infective endocarditis and heart failure, valvular surgery associated with reduced mortality." ScienceDaily. www.sciencedaily.com/releases/2011/11/111122162822.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Nurse Nina Pham Cured of Ebola

Texas Nurse Nina Pham Cured of Ebola

AFP (Oct. 25, 2014) — An American nurse who contracted Ebola while caring for a Liberian patient in Texas has been declared free of the virus and will leave the hospital. Duration: 01:01 Video provided by AFP
Powered by NewsLook.com
Toxin-Packed Stem Cells Used To Kill Cancer

Toxin-Packed Stem Cells Used To Kill Cancer

Newsy (Oct. 25, 2014) — A Harvard University Research Team created genetically engineered stem cells that are able to kill cancer cells, while leaving other cells unharmed. Video provided by Newsy
Powered by NewsLook.com
IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) — IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) — A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins